Atrial and Ventricular Cannulation for Biventricular Circulatory Support With Double‐Ended Centrifugal Pump: In Vitro Evaluation
Artificial Organs · 2025
DOI: 10.1111/aor.14959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Christine R Flick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure, Catheterization. Die Arbeit nennt 18 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Background
In patients with biventricular heart failure, a biventricular assist device (BVAD) may be necessary for hemodynamic support. BVAD inflows can be established through cannulation of the atrial (AC) and/or ventricular (VC) chambers, but no consensus exists on optimal cannulation techniques. This study aimed to characterize BVAD performance related to cannulation types (AC and VC) using a continuous‐flow total artificial heart (CFTAH) as the BVAD.
Methods
Both methods of cannulation (AC and VC) were tested on a mock loop using dual pulsatile ventricles with valves (AB5000; Abiomed) paired as the native ventricles and a double‐ended centrifugal pump with two volutes, CFTAH, as a BVAD. Pressures were collected at the inlet and outlets of the AB5000 (LAP, RAP, AoP, and PAP) and the CFTAH (Lin, Rin, Lout, and Rout). The left and right flows exiting the CFTAH (LPF and RPF) and total flow (TF), exiting systemic resistance, were monitored. Several heart failure conditions were simulated with adjustment of the pneumatic pressures (AB5000).
Results
Trends between the AC and VC are similar where RAP, Lin, and Lout decreased, and AoP, PAP, TF, LPF, and RPF increased with increased support. The trends differ in LAP with an increase during AC as opposed to a decrease during VC. As a result, with this setup, left–right balance is more easily achieved during VC. TF is higher with AC, even though LPF and RPF are lower. This signifies the flow going through the aortic valve (TF–LPF) and pulmonary valve (TF–RPF) is higher with AC.
Conclusions
The increased TF and valvular flow favored AC for introducing a CFTAH as BVAD to the native heart in these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Christine R Flick, Chihiro Miyagi, Anthony R Polakowski, Kiyotaka Fukamachi, Jamshid H Karimov
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Heart, Lung, and Blood Institute
- National Institutes of Health
Zitieren
APA
Flick, C. R., Miyagi, C., Kuban, B. D., Polakowski, A. R., Fukamachi, K., Kuroda, T., & Karimov, J. H. (2025). Atrial and Ventricular Cannulation for Biventricular Circulatory Support With Double‐Ended Centrifugal Pump: In Vitro Evaluation. Artificial Organs. https://doi.org/10.1111/aor.14959
Vancouver
Flick CR, Miyagi C, Kuban BD, Polakowski AR, Fukamachi K, Kuroda T, et al. Atrial and Ventricular Cannulation for Biventricular Circulatory Support With Double‐Ended Centrifugal Pump: In Vitro Evaluation. Artificial Organs. 2025. doi:10.1111/aor.14959
BibTeX
@article{Flick2025,
author = {Flick, Christine R and Miyagi, Chihiro and Kuban, Barry D and Polakowski, Anthony R and Fukamachi, Kiyotaka and Kuroda, Taiyo and Karimov, Jamshid H},
title = {Atrial and Ventricular Cannulation for Biventricular Circulatory Support With Double‐Ended Centrifugal Pump: In Vitro Evaluation},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14959}
}
EUVIMED